|
Dependent variables
|
MRSA estimate (95% CI)
|
P value
|
Model r2
|
|---|
|
Total MV (days)
|
4.4 (0.6 to 8.2)
|
0.03
|
0.16
|
|
VAP MV (days)
|
4.5 (1.0 to 8.1)
|
0.01
|
0.10
|
|
Total inpatient LOS (days)
|
3.8 (-0.5 to +8.0)
|
0.08
|
0.26
|
|
VAP inpatient LOS (days)
|
3.7 (-0.5 to +8.0)
|
0.08
|
0.06
|
|
Total ICU (days)a
|
5.3 (1.0 to 9.7)
|
0.02
|
0.13
|
|
VAP ICU (days)a
|
4.4 (0.4 to 8.4)
|
0.03
|
0.10
|
|
Total cost (US$)
|
7731 (-8393 to +23,856)
|
0.35
|
0.28
|
- A total of 154 patients were included in this analysis. aAnalysis for ICU days was conducted on patients (n = 95) from hospitals that collect ICU stay data. CI, confidence interval; ICU, intensive care unit; LOS, length of stay; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; MV, mechanical ventilation; VAP, ventilator-associated pneumonia.
